TFF Pharmaceuticals Announces Presentation of Data Featuring Applications of Thin Film Freezing Technology at AAPS PharmSci 360 Meeting

~ Two Presentations Featuring Thin Film Freezing Technology Selected for the Meeting’s Special Poster Collections ~ Demonstrates Use of Thin Film Freezing to Produce Dry Powder Inhaled Formulations of Monoclonal Antibodies and Applications of Machine Learning to Predict Aerosol Performance of Dry Powders for Inhalation ~ Highlights the Company’s Strategic Focus of Expanding its Biologics Product Portfolio

Daniel Carlson

October 11, 2022

Thank you for visiting Tailwinds Research. We are pleased to offer free research on select small and micro cap companies. It is free to join and we hope you’ll take the time to do so.

To create an account please click on this link.

If you already have an account, please log in here.

4 COMMENTS

Neil Gerber October 15, 2022 at 9:23 pm

You need to login to view this content.

Reply
- Daniel Carlson October 16, 2022 at 7:17 am
  
  You need to login to view this content.
  
  Reply
wpeter41 October 12, 2022 at 3:38 pm

You need to login to view this content.

Reply
- Daniel Carlson October 14, 2022 at 2:44 pm
  
  You need to login to view this content.
  
  Reply

LEAVE A REPLY Cancel reply

DFC Advisory Services LLC (dba TW Research Group) is an investment adviser. We are also compensated for publishing information on certain companies. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.